Feb 25 (Reuters) – Private equity group EQT said on Wednesday it had decided not to proceed with a takeover offer for Oxford Biomedica, sending the British cell and gene therapy manufacturer’s shares down nearly 10%.
(Reporting by Ankita Bora in Bengaluru; Editing by Shreya Biswas)
